News

Identifying the Role of R-BAC Maintenance in MCL

Andre Goy, M.D., chief in the division of lymphoma, chair and director at John Theurer Cancer Center, discusses the role of rituximab (Rituxan) and bendamustine plus cytarabine (R-BAC) as a treatment for patients with mantle cell lymphoma (MCL).

READ FULL ARTICLE ON TARGETEDONC.COM